Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
作者信息
Bailleul Els, Van Vaerenbergh Kristien, Lust Antoon
出版信息
Thromb Haemost. 2005 Sep;94(3):687; author reply 688. doi: 10.1160/TH05-03-0687.
PMID:16268495
Abstract
摘要
相似文献
1
Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
Thromb Haemost. 2005 Sep;94(3):687; author reply 688. doi: 10.1160/TH05-03-0687.
2
3
Sample carryover in PT-INR determination is it an issue in Oral Anticoagulant Therapy control?
Thromb Res. 2011 Mar;127(3):279-81. doi: 10.1016/j.thromres.2010.10.020. Epub 2010 Dec 3.
4
Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
Thromb Res. 2004;114(2):83-9. doi: 10.1016/j.thromres.2004.04.010.
5
Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH.
J Thromb Haemost. 2016 Nov;14(11):2304-2307. doi: 10.1111/jth.13481. Epub 2016 Nov 7.
6
Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Thromb Haemost. 2009 Jul;102(1):159-65. doi: 10.1160/TH09-01-0056.
7
Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.
WMJ. 2000 Jun;99(3):62-4, 43.
8
False incoagulable PT-INR results in oral anticoagulant therapy.
Thromb Res. 2008;122(1):137-9. doi: 10.1016/j.thromres.2007.09.013. Epub 2007 Nov 9.
9
A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy.
Clin Chem Lab Med. 2006;44(10):1214-7. doi: 10.1515/CCLM.2006.217.
10
Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
Semin Vasc Med. 2003 Aug;3(3):243-54. doi: 10.1055/s-2003-44460.
Zotero 插件